
Aupeg
- Strength
- 3750IU/5ml
- Manufacturer
- Kings Global Biotech Ltd
- Availability
- Available to source
Pegaspargase 3750IU/5ml — Injection, 1's Vial
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
Aupeg uses and dosage
AUPEG (Pegaspargase), Generic ONCASPAR is a prescription medicine used to treat acute Lymphoblastic Leukemia (ALL) in both pediatric and adult patients. Pegaspargase is commonly administered as part of a multi-agent chemotherapeutic regimen, which may include drugs such as anthracyclines, vincristine, and corticosteroids. The mechanism of action of Pegaspargase involves the depletion of the amino acid asparagine, which is essential for the survival of tumor cells. By depriving the tumor cells of asparagine, Pegaspargase induces apoptosis, leading to the death of the malignant cells. This medication is typically delivered through intravenous infusion or intramuscular injection, depending on the specific treatment protocol and patient needs. AUPEG is manufactured by by Kings Global Biotech Ltd. in India. Pegaspargase medication is given by injection into a vein by a health care professi
Indications
Aupeg side effects
The most common side effects of Pegaspargase are: Nausea, vomiting, weakness, diarrhea, or pain/swelling/redness.
- Originator brand
- ONCASPAR by SIGMA TAU
- Made by
- Kings Global Biotech Ltd
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.



